409 related articles for article (PubMed ID: 25461735)
1. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects.
Jannes CE; Santos RD; de Souza Silva PR; Turolla L; Gagliardi AC; Marsiglia JD; Chacra AP; Miname MH; Rocha VZ; Filho WS; Krieger JE; Pereira AC
Atherosclerosis; 2015 Jan; 238(1):101-7. PubMed ID: 25461735
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of familial hypercholesterolemia in Spain.
Palacios L; Grandoso L; Cuevas N; Olano-Martín E; Martinez A; Tejedor D; Stef M
Atherosclerosis; 2012 Mar; 221(1):137-42. PubMed ID: 22244043
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia.
Chiou KR; Charng MJ
Am J Cardiol; 2010 Jun; 105(12):1752-8. PubMed ID: 20538126
[TBL] [Abstract][Full Text] [Related]
4. A DNA microarray for the detection of point mutations and copy number variation causing familial hypercholesterolemia in Europe.
Stef MA; Palacios L; Olano-Martín E; Foe-A-Man C; van de Kerkhof L; Klaaijsen LN; Molano A; Schuurman EJ; Tejedor D; Defesche JC
J Mol Diagn; 2013 May; 15(3):362-72. PubMed ID: 23537714
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of familial hypercholesterolaemia in Western Australia.
Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
[TBL] [Abstract][Full Text] [Related]
6. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
Tada H; Kawashiri MA; Ohtani R; Noguchi T; Nakanishi C; Konno T; Hayashi K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
Atherosclerosis; 2011 Dec; 219(2):663-6. PubMed ID: 21872251
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family.
Lin J; Wang LY; Liu S; Wang XM; Yong Q; Yang Y; DU LP; Pan XD; Wang X; Jiang ZS
Chin Med J (Engl); 2010 May; 123(9):1133-8. PubMed ID: 20529551
[TBL] [Abstract][Full Text] [Related]
8. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland.
Sharifi M; Walus-Miarka M; Idzior-Waluś B; Malecki MT; Sanak M; Whittall R; Li KW; Futema M; Humphries SE
Metabolism; 2016 Mar; 65(3):48-53. PubMed ID: 26892515
[TBL] [Abstract][Full Text] [Related]
9. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
[TBL] [Abstract][Full Text] [Related]
10. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
Saavedra YG; Dufour R; Davignon J; Baass A
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico.
Robles-Osorio L; Huerta-Zepeda A; Ordóñez ML; Canizales-Quinteros S; Díaz-Villaseñor A; Gutiérrez-Aguilar R; Riba L; Huertas-Vázquez A; Rodríguez-Torres M; Gómez-Díaz RA; Salinas S; Ongay-Larios L; Codiz-Huerta G; Mora-Cabrera M; Mehta R; Gómez Pérez FJ; Rull JA; Rabès JP; Tusié-Luna MT; Durán-Vargas S; Aguilar-Salinas CA
Arch Med Res; 2006 Jan; 37(1):102-8. PubMed ID: 16314194
[TBL] [Abstract][Full Text] [Related]
12. The genetic spectrum of familial hypercholesterolemia in Pakistan.
Ahmed W; Whittall R; Riaz M; Ajmal M; Sadeque A; Ayub H; Qamar R; Humphries SE
Clin Chim Acta; 2013 Jun; 421():219-25. PubMed ID: 23535506
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.
Cameron J; Bogsrud MP; Tveten K; Strøm TB; Holven K; Berge KE; Leren TP
Transl Res; 2012 Aug; 160(2):125-30. PubMed ID: 22683370
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy.
Romano M; Di Taranto MD; D'Agostino MN; Marotta G; Gentile M; Abate G; Mirabelli P; Di Noto R; Del Vecchio L; Rubba P; Fortunato G
Atherosclerosis; 2010 Jun; 210(2):493-6. PubMed ID: 20045108
[TBL] [Abstract][Full Text] [Related]
15. Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia.
Fouchier SW; Dallinga-Thie GM; Meijers JC; Zelcer N; Kastelein JJ; Defesche JC; Hovingh GK
Circ Res; 2014 Aug; 115(6):552-5. PubMed ID: 25035151
[TBL] [Abstract][Full Text] [Related]
16. [Familial hypercholesterolemia in Tunisia].
Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN
Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195
[TBL] [Abstract][Full Text] [Related]
17. Array-based resequencing for mutations causing familial hypercholesterolemia.
Chiou KR; Charng MJ; Chang HM
Atherosclerosis; 2011 Jun; 216(2):383-9. PubMed ID: 21376320
[TBL] [Abstract][Full Text] [Related]
18. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia.
Motazacker MM; Pirruccello J; Huijgen R; Do R; Gabriel S; Peter J; Kuivenhoven JA; Defesche JC; Kastelein JJ; Hovingh GK; Zelcer N; Kathiresan S; Fouchier SW
Eur Heart J; 2012 Jun; 33(11):1360-6. PubMed ID: 22408029
[TBL] [Abstract][Full Text] [Related]
19. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
Page MM; Stefanutti C; Sniderman A; Watts GF
Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
